InMed Pharmaceuticals (INM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.32, -0.75% vs the prior close of $1.33.
- Volume 4.33K shares, 0.1x its 50-day average (light).
- New SEC filings: 4 (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
INM dips 0.8% to $1.32. Closed at $1.32, -0.75% vs the prior close of $1.33. Day range $1.32–$1.34, opened at $1.32.
INM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — INM dips 0.8% to $1.32
- Closed at $1.32, -0.75% vs the prior close of $1.33. Day range $1.32–$1.34, opened at $1.32.
- Volume was 4.33K shares, 0.1x its 50-day average of 64.92K — lighter than usual.
- Price is -4.3% vs its 50-day average ($1.38) and +11.3% vs its 200-day average ($1.19).
- 52-week range $0.57–$2.33; today's close sits at 42% of that range, 43.3% below the 52-week high.
Oct 15, 2026 — INM rises 1.5% to $1.33
- Closed at $1.33, +1.53% vs the prior close of $1.31. Day range $1.31–$1.34, opened at $1.31.
- Volume was 17.60K shares, 0.3x its 50-day average of 66.94K — lighter than usual.
- Price is -3.7% vs its 50-day average ($1.38) and +12.2% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.33; today's close sits at 43% of that range, 42.9% below the 52-week high.
Oct 14, 2026 — INM dips 1.5% to $1.31, 3 down days in a row
- Closed at $1.31, -1.50% vs the prior close of $1.33. Day range $1.31–$1.36, opened at $1.35.
- Volume was 29.80K shares, 0.4x its 50-day average of 67.77K — lighter than usual.
- Price is -5.2% vs its 50-day average ($1.38) and +10.6% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.33; today's close sits at 42% of that range, 43.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — INM dips 2.2% to $1.33
- Closed at $1.33, -2.21% vs the prior close of $1.36. Day range $1.33–$1.37, opened at $1.34.
- Volume was 28.10K shares, 0.4x its 50-day average of 68.47K — lighter than usual.
- Price is -4.0% vs its 50-day average ($1.39) and +12.3% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.33; today's close sits at 43% of that range, 42.9% below the 52-week high.
Oct 12, 2026 — INM ends flat (+0.0%) to $1.36
- Closed at $1.36, +0.00% vs the prior close of $1.36. Day range $1.36–$1.40, opened at $1.39.
- Volume was 28.80K shares, 0.4x its 50-day average of 73.06K — lighter than usual.
- Price is -2.1% vs its 50-day average ($1.39) and +14.9% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.40; today's close sits at 43% of that range, 43.3% below the 52-week high.
Oct 9, 2026 — INM rises 2.3% to $1.36
- Closed at $1.36, +2.26% vs the prior close of $1.33. Day range $1.35–$1.44, opened at $1.35.
- Volume was 55.80K shares, 0.7x its 50-day average of 77.07K.
- Price is -2.2% vs its 50-day average ($1.39) and +15.0% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.44; today's close sits at 42% of that range, 44.3% below the 52-week high.
Oct 8, 2026 — INM ends flat (+0.0%) to $1.33, 7 down days in a row
- Closed at $1.33, +0.00% vs the prior close of $1.33. Day range $1.32–$1.36, opened at $1.32.
- Volume was 26.80K shares, 0.3x its 50-day average of 80.88K — lighter than usual.
- Price is -4.6% vs its 50-day average ($1.39) and +12.5% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.50; today's close sits at 39% of that range, 46.8% below the 52-week high.
- That makes 7 straight losses.
Oct 7, 2026 — INM ends flat (+0.0%) to $1.33, 6 down days in a row
- Closed at $1.33, +0.00% vs the prior close of $1.33. Day range $1.33–$1.35, opened at $1.35.
- Volume was 16.10K shares, 0.2x its 50-day average of 83.37K — lighter than usual.
- Price is -5.0% vs its 50-day average ($1.40) and +12.6% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.50; today's close sits at 39% of that range, 46.8% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — INM ends flat (+0.0%) to $1.33, 5 down days in a row
- Closed at $1.33, +0.00% vs the prior close of $1.33. Day range $1.32–$1.38, opened at $1.38.
- Volume was 17.70K shares, 0.2x its 50-day average of 89.73K — lighter than usual.
- Price is -5.5% vs its 50-day average ($1.41) and +12.6% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.50; today's close sits at 39% of that range, 46.8% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — INM ends flat (+0.0%) to $1.33, 4 down days in a row
- Closed at $1.33, +0.00% vs the prior close of $1.33. Day range $1.33–$1.39, opened at $1.36.
- Volume was 29.60K shares, 0.3x its 50-day average of 95.78K — lighter than usual.
- Price is -5.9% vs its 50-day average ($1.41) and +12.6% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.50; today's close sits at 39% of that range, 46.8% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — INM dips 1.5% to $1.33, 3 down days in a row
- Closed at $1.33, -1.48% vs the prior close of $1.35. Day range $1.33–$1.38, opened at $1.37.
- Volume was 28.30K shares, 0.2x its 50-day average of 121.54K — lighter than usual.
- Price is -6.4% vs its 50-day average ($1.42) and +12.6% vs its 200-day average ($1.18).
- 52-week range $0.57–$2.50; today's close sits at 39% of that range, 46.8% below the 52-week high.
- That makes 3 straight losses.
INM latest news & SEC filings
Every SEC filing by or about INM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 564 shares at $1.33 (≈$750) on Oct 13, 2026; now holds 946,488
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 8,021 shares at $1.33 (≈$10.67K) on Oct 14, 2026; now holds 954,509
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 984 shares at $1.32 (≈$1.30K) on Oct 15, 2026; now holds 955,493
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 5,601 shares at $1.33 (≈$7.44K) on Oct 6, 2026; now holds 940,622
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 3,046 shares at $1.33 (≈$4.05K) on Oct 7, 2026; now holds 943,668
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 2,256 shares at $1.33 (≈$3.00K) on Oct 8, 2026; now holds 945,924
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 16,431 shares at $1.33 (≈$21.85K) on Oct 1, 2026; now holds 908,532
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 8,307 shares at $1.33 (≈$11.05K) on Oct 2, 2026; now holds 916,839
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 18,182 shares at $1.33 (≈$24.18K) on Oct 5, 2026; now holds 935,021
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 28,505 shares at $1.29 (≈$36.88K) on Sep 14, 2026; now holds 829,505
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 54,256 shares at $1.30 (≈$70.45K) on Sep 15, 2026; now holds 883,761
- Adar1 Capital Management, Llc & Schneeberger Daniel bought 8,340 shares at $1.29 (≈$10.75K) on Sep 16, 2026; now holds 892,101
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$12.56M (prior year -$8.16M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$3.12 (prior year -$8.36) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade INM
- Last results release: Nov 13, 2020 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 0.99% (largest 2.3%). That is a relatively calm stock.
- Liquidity: about 43.44K shares (≈$57.34K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.32 vs a range of $0.57–$2.33 (42% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Nov 14, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Daniel Schneeberger bought 8,340 shares on Sep 16, 2026.
- Latest filings: 8-K Sep 18, 2026; 10-K Sep 9, 2026; 8-K Jul 22, 2026.
- Share count: 5.49M shares outstanding (Sep 2, 2026), +130.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
INM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.32 | 1.34 | 1.32 | 1.32 | 4.33K |
| Oct 15, 2026 | 1.31 | 1.34 | 1.31 | 1.33 | 17.60K |
| Oct 14, 2026 | 1.35 | 1.36 | 1.31 | 1.31 | 29.80K |
| Oct 13, 2026 | 1.34 | 1.37 | 1.33 | 1.33 | 28.10K |
| Oct 12, 2026 | 1.39 | 1.40 | 1.36 | 1.36 | 28.80K |
| Oct 9, 2026 | 1.35 | 1.44 | 1.35 | 1.36 | 55.80K |
| Oct 8, 2026 | 1.32 | 1.36 | 1.32 | 1.33 | 26.80K |
| Oct 7, 2026 | 1.35 | 1.35 | 1.33 | 1.33 | 16.10K |
| Oct 6, 2026 | 1.38 | 1.38 | 1.32 | 1.33 | 17.70K |
| Oct 5, 2026 | 1.36 | 1.39 | 1.33 | 1.33 | 29.60K |
| Oct 2, 2026 | 1.37 | 1.38 | 1.33 | 1.33 | 28.30K |
| Oct 1, 2026 | 1.34 | 1.37 | 1.32 | 1.35 | 100.00K |
| Sep 30, 2026 | 1.35 | 1.41 | 1.34 | 1.36 | 60.70K |
| Sep 29, 2026 | 1.35 | 1.42 | 1.34 | 1.38 | 60.50K |
| Sep 28, 2026 | 1.36 | 1.37 | 1.36 | 1.36 | 17.40K |
| Sep 25, 2026 | 1.38 | 1.40 | 1.35 | 1.38 | 100.70K |
| Sep 24, 2026 | 1.39 | 1.42 | 1.37 | 1.40 | 39.00K |
| Sep 23, 2026 | 1.39 | 1.41 | 1.38 | 1.38 | 49.20K |
| Sep 22, 2026 | 1.39 | 1.44 | 1.37 | 1.39 | 38.30K |
| Sep 21, 2026 | 1.38 | 1.46 | 1.37 | 1.38 | 120.00K |
About InMed Pharmaceuticals
InMed Pharmaceuticals (INM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in VANCOUVER. State of incorporation: British Columbia, Canada. Fiscal year ends June 30. SEC CIK 1728328.
INM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Eric A Adams | President & CEO | Dec 19, 2025 |
| John Steven Bathery | Director | Dec 19, 2025 |
| Andrew Hull | Director | Dec 19, 2025 |
| Neil A Klompas | Director | Dec 19, 2025 |
| Nicole Lemerond | Director | Dec 19, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Eric A Adams | President & CEO | Dec 19, 2025 |
| Eric C Hsu | Sr. VP, Pre-Clinical Res/Dev | Dec 19, 2025 |
| Netta Jagpal | Chief Financial Officer | Dec 19, 2025 |
| Shane Aaron Johnson | Sr VP & General Manager | Dec 19, 2025 |
| Michael Woudenberg | Chief Operating Officer | Dec 19, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Daniel Schneeberger | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Daniel Schneeberger | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Capital Management, Llc Adar1 | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Capital Management, Llc Adar1 | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Daniel Schneeberger | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Daniel Schneeberger | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Capital Management, Llc Adar1 | Buy | 8,340 | $1.29 |
| Sep 16, 2026 | Capital Management, Llc Adar1 | Buy | 8,340 | $1.29 |
| Sep 15, 2026 | Daniel Schneeberger | Buy | 54,256 | $1.30 |
| Sep 15, 2026 | Daniel Schneeberger | Buy | 54,256 | $1.30 |
| Sep 15, 2026 | Capital Management, Llc Adar1 | Buy | 54,256 | $1.30 |
| Sep 15, 2026 | Capital Management, Llc Adar1 | Buy | 54,256 | $1.30 |
| Sep 15, 2026 | Daniel Schneeberger | Buy | 54,256 | $1.30 |
| Sep 15, 2026 | Daniel Schneeberger | Buy | 54,256 | $1.30 |
| Sep 15, 2026 | Capital Management, Llc Adar1 | Buy | 54,256 | $1.30 |
INM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-12.56M | -3.12 | $-8.64M |
| Jun 30, 2025 | — | $-8.16M | -8.36 | $-8.10M |
| Jun 30, 2024 | — | $-7.68M | -20.14 | $-6.99M |
| Jun 30, 2023 | — | $-7.95M | -3.25 | $-7.28M |
| Jun 30, 2022 | $1.37M | $-18.60M | -33.17 | $-15.58M |
Latest balance sheet: total assets $3.03M, total liabilities $1.96M, cash $5.16M (as of Jun 30, 2026).
INM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 13, 2020 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on INM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.